Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)

Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are now uncovering new possibilities in the field of internal medicine owing to their diverse protective effects. In the second part of the literature review, we explore potential applications of SGLT2i in hepatology, neurology, ophthalmology, and o...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashot A. Avagimyan, Mohammad Sheibani, Artem I. Trofimenko, Evgenii E. Lysov, Farida M. Khamidova, Anahit Z. Aznauryan, Lilit M. Sukiasyan, Karmen T. Sahakyan, Tamara R. Gevorgyan, Marina R. Tatoyan, Gayane L. Mkrtchyan, Goharik L. Meltonyan, Anna R. Petrosyan, Ludmila A. Martemyanova, Ruzanna R. Petrosyan, Olga I. Urazova, Nana V. Pogosova, Nizal Sarrafzadegan
Format: Article
Language:English
Published: Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1 2025-02-01
Series:Инновационная медицина Кубани
Subjects:
hepatoprotection
neuroprotection
retinoprotection
oncoprotection
dapagliflozin
empagliflozin
canagliflozin
Online Access:https://www.innovmedkub.ru/jour/article/view/1072
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are now uncovering new possibilities in the field of internal medicine owing to their diverse protective effects. In the second part of the literature review, we explore potential applications of SGLT2i in hepatology, neurology, ophthalmology, and oncology, mechanisms of action of such drugs as dapagliflozin, empagliflozin, canagliflozin, etc, and their effect on different organs and systems.
ISSN:2541-9897

Similar Items